HomeInvesting NewsPfizer Stock Rises, Company to Provide Global Fund With up to 6...

Pfizer Stock Rises, Company to Provide Global Fund With up to 6 Million Paxlovid Therapy Courses to Treat COVID

Published on

Pfizer stock is up at $44.71 as of 10:49 AM EDT on Thursday.

As part of its COVID-19 Response Mechanism, Pfizer (NYSE:PFE) struck an agreement to provide up to 6 million treatment courses of its COVID-19 oral medication Paxlovid to the Global Fund (C19RM).

The 132 low- and middle-income nations that qualify for the Global Fund will be able to purchase the medication beginning this year, pending local regulatory permission or authorization, the company announced in a news statement on September 22.

According to Pfizer, C19RM has been the primary method for giving low- and middle-income countries grant funding to purchase COVID-19 tests, treatments, and personal protective equipment, among other things.

The company noted that all low- and lower-middle-income nations will pay a not-for-profit price, while upper-middle-income nations will pay the price stipulated by Pfizer’s tiered pricing strategy.

In March, Pfizer agreed to give UNICEF access to up to 4 million Paxlovid (nirmatrelvir/ritonavir pills) treatment courses for 95 low- and middle-income nations. 

Pfizer Announces Q4 Dividend for 2022

Pfizer Inc. ( NYSE:PFE) issued a $0.40 dividend on the company’s common stock for the fourth quarter of 2022. The dividend is payable on December 5, 2022, to holders of record as of the close of business on November 4, 2022. The Q4 cash dividend of 2022 will mark Pfizer‘s 336th successive quarterly dividend payment.

Pfizer stock, Financials

Pfizer Inc. (NYSE:PFE) provided a webcast of a conference call with financial analysts for investors and the general public to observe and listen to. The call’s objective is to offer a status report on Pfizer stock’s performance as it will be detailed in the company’s Third Quarter 2022 Performance Report, which will be released that morning.

Featured Image-  Megapixl @Michaelvi

Please See Disclaimer

Latest News

Raytheon Stock Plunged After It Said It Won a $160 Million Contract for a Dual-Band Radar.

Raytheon Stock (NYSE:RTX) Raytheon stock declined after the company announced that it had just won...

Jblu Stock up and Joins American Airlines to Defend Their Alliance in Court

JBLU stock was up, trading at 6.99 as of 10:21 AM EDT on Monday The...

Target Stock Falls as the Retailer Promised to Provide Excellent Holiday Savings and Values.

Target Stock (NYSE:TGT) To match the excitement of holiday customers, stores have started preparing for...

Lyft Stock Drops as Ubs Lowers Its Ratings and Slashes Its Forecast

Lyft stock slightly slid to $13.72 at 10:07 AM EDT on Monday. On Monday, Lyft...

More like this

Here’s Why ChargePoint Stock Dropped Today

ChargePoint Stock (NYSE:CHPT) The ChargePoint stock fell today, along with several other riskier securities. At...

Investors Dumped Meta Stock After Hearing That Trump May Be Allowed to Return to Facebook in 2023.

Meta Stock (NASDAQ:META) Meta stock is down after Nick Clegg, the policy leader at Meta...

Moderna Stock Stayed Flat as It Asked FDA to Approve Enhanced COVID Boosters for Kids.

Moderna Stock (NASDAQ:MRNA) Moderna stock didn't move much because the Centers for Disease Control and...

Okta Stock Fell to a New All-Time Low as Cleveland Research Downgraded the Company for Many Reasons.

Okta Stock (NASDAQ:OKTA) Okta stock went into the red during early trading on Friday after...

Google Stock Didn’t Move After a Staff Meeting Revealed Negative Sentiment on Budget Cuts.

Google Stock (NASDAQ:GOOG) (NASDAQ:GOOGL) According to CNBC's reporting, Google stock remained stagnant after CEO Sundar...

Microsoft Stock; Is It Cheap?

Microsoft Stock (NASDAQ:MSFT) Microsoft stock (NASDAQ:MSFT) is one of my favorite investments, and like many...